Kiwi scientists develop powerful melanoma research tool
16 July 2020
A nationwide group of researchers from the Maurice Wilkins Centre has recently reported a detailed characterisation of one of the largest melanoma cell line panels ever developed that makes this a resource for research of international importance.
MWC assisting with Samoa’s COVID-19 testing
5 July 2020
The Maurice Wilkins Centre has been working with the Scientific Research Organisation of Samoa (SROS) to obtain relevant equipment and protocols required for COVID-19 testing in Samoa.
Getting New Zealand's only COVID-19 lab up and running
10 June 2020
While most of the country was in lockdown, a small team led by MWC investigators Professor Miguel Quiñones-Mateu and Associate Professor James Ussher were in their University of Otago lab working to isolate the COVID-19 virus from New Zealand patient samples.
MWC investigator backs COVID-19 vaccine search
27 May 2020
New Zealand scientists have already identified a number of potential COVID-19 vaccine candidates, according to Associate Professor James Ussher, MWC Associate Investigator at the University of Otago.
COVID-19 antibody testing underway in MWC labs
22 May 2020
MWC Principal Investigator Dr Nikki Moreland, Immunologist and Senior Lecturer at the University of Auckland, is working with a team of researchers on lab-based COVID-19 antibody tests in a bid to better understand the body's immune response to the virus.
MWC researchers identify novel drug target for TB
14 May 2020
Several researchers from the Maurice Wilkins Centre are co-authors on a recent paper reporting a novel mechanism for controlling the synthesis of essential vitamin K2 in the bacterial pathogen that causes tuberculosis.
MWC team awarded funding for COVID-19 research
3 May 2020
MWC researchers at the University of Auckland have been awarded Auckland Medical Research Foundation (AMRF) funding to investigate whether certain types of patent could be used for COVID-19 antiviral drug development.
MWC link to promising COVID-19 treatment
24 April 2020
Professor Peter Tyler, MWC Associate Investigator at the Ferrier Research Institute, Victoria University of Wellington, created the antiviral drug Galidesivir which is in the front-running for potential use in the treatment of COVID-19.